Annual Operating Profit
-$524.30 M
-$63.45 M-13.77%
01 December 2023
Summary:
Sinovac Biotech annual operaing income is currently -$524.30 million, with the most recent change of -$63.45 million (-13.77%) on 01 December 2023. During the last 3 years, it has fallen by -$740.11 million (-342.95%). SVA annual operating profit is now -102.99% below its all-time high of $17.55 billion, reached on 31 December 2021.SVA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
N/A
01 June 2024
Summary:
Sinovac Biotech quarterly operating income is not available.SVA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
N/A
01 June 2024
Summary:
Sinovac Biotech TTM operating income is not available.SVA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -342.9% | - | - |
| 5 y5 years | -1255.1% | - | - |
SVA Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -103.0% | at low | ||||
| 5 y | 5 years | -103.0% | at low | ||||
| alltime | all time | -103.0% | at low |
Sinovac Biotech Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$524.30 M(+13.8%) | - | - |
| Dec 2022 | -$460.85 M(-102.6%) | - | - |
| Dec 2021 | $17.55 B(+8034.2%) | - | - |
| Dec 2020 | $215.81 M(+213.4%) | $197.04 M(+609.3%) | $215.81 M(+353.0%) |
| Sept 2020 | - | $27.78 M(<-9900.0%) | $47.64 M(+40.9%) |
| June 2020 | - | -$178.00 K(-98.0%) | $33.80 M(-38.6%) |
| Mar 2020 | - | -$8.83 M(-130.6%) | $55.05 M(-20.1%) |
| Dec 2019 | $68.86 M(+51.7%) | $28.87 M(+107.0%) | $68.86 M(+71.0%) |
| Sept 2019 | - | $13.94 M(-33.8%) | $40.27 M(-5.7%) |
| June 2019 | - | $21.07 M(+323.2%) | $42.71 M(+20.5%) |
| Mar 2019 | - | $4.98 M(+1684.2%) | $35.46 M(-21.9%) |
| Dec 2018 | $45.39 M(-0.1%) | $279.00 K(-98.3%) | $45.42 M(+0.6%) |
| Sept 2018 | - | $16.39 M(+18.6%) | $45.15 M(+57.0%) |
| June 2018 | - | $13.81 M(-7.6%) | $28.76 M(+92.4%) |
| Mar 2018 | - | $14.94 M(+48.9%) | $14.94 M(+1421.7%) |
| Dec 2017 | $45.46 M(+4529.2%) | - | - |
| Dec 2016 | $982.00 K(-73.6%) | $10.04 M(+57.5%) | $982.00 K(-115.7%) |
| Sept 2016 | - | $6.37 M(-146.5%) | -$6.26 M(-55.1%) |
| June 2016 | - | -$13.71 M(+698.5%) | -$13.94 M(-447.4%) |
| Mar 2016 | - | -$1.72 M(-161.4%) | $4.01 M(+7.9%) |
| Dec 2015 | $3.72 M(+89.9%) | $2.80 M(-312.9%) | $3.72 M(-13.4%) |
| Sept 2015 | - | -$1.31 M(-130.9%) | $4.29 M(-34.0%) |
| June 2015 | - | $4.25 M(-311.2%) | $6.50 M(-1079.5%) |
| Mar 2015 | - | -$2.01 M(-159.6%) | -$664.00 K(-133.9%) |
| Dec 2014 | $1.96 M(-80.5%) | $3.37 M(+276.9%) | $1.96 M(-65.5%) |
| Sept 2014 | - | $895.00 K(-130.6%) | $5.68 M(-27.1%) |
| June 2014 | - | -$2.92 M(-577.3%) | $7.79 M(-39.5%) |
| Mar 2014 | - | $612.00 K(-91.4%) | $12.87 M(+28.0%) |
| Dec 2013 | $10.03 M(-152.9%) | $7.10 M(+136.3%) | $10.05 M(>+9900.0%) |
| Sept 2013 | - | $3.00 M(+39.1%) | $28.90 K(-100.4%) |
| June 2013 | - | $2.16 M(-197.9%) | -$7.53 M(-42.0%) |
| Mar 2013 | - | -$2.21 M(-24.7%) | -$12.99 M(-31.5%) |
| Dec 2012 | -$18.96 M(-595.2%) | -$2.93 M(-35.7%) | -$18.96 M(+105.2%) |
| Sept 2012 | - | -$4.56 M(+38.2%) | -$9.24 M(+25.8%) |
| June 2012 | - | -$3.30 M(-59.7%) | -$7.35 M(+698.1%) |
| Mar 2012 | - | -$8.18 M(-220.4%) | -$920.70 K(-124.7%) |
| Dec 2011 | $3.83 M | $6.79 M(-355.1%) | $3.73 M(-122.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$2.66 M(-185.1%) | -$16.29 M(+13.9%) |
| June 2011 | - | $3.13 M(-188.7%) | -$14.30 M(-3.6%) |
| Mar 2011 | - | -$3.53 M(-73.3%) | -$14.83 M(+22.4%) |
| Dec 2010 | -$12.12 M(-129.7%) | -$13.23 M(+1874.1%) | -$12.12 M(-166.5%) |
| Sept 2010 | - | -$670.20 K(-125.8%) | $18.23 M(-41.8%) |
| June 2010 | - | $2.60 M(-419.1%) | $31.31 M(-20.5%) |
| Mar 2010 | - | -$813.50 K(-104.8%) | $39.39 M(-3.6%) |
| Dec 2009 | $40.85 M(+160.1%) | $17.12 M(+38.0%) | $40.85 M(+51.5%) |
| Sept 2009 | - | $12.41 M(+16.2%) | $26.96 M(+59.8%) |
| June 2009 | - | $10.68 M(+1552.0%) | $16.87 M(+27.6%) |
| Mar 2009 | - | $646.40 K(-80.0%) | $13.22 M(-15.8%) |
| Dec 2008 | $15.71 M(+16.6%) | $3.23 M(+39.8%) | $15.71 M(-0.4%) |
| Sept 2008 | - | $2.31 M(-67.1%) | $15.77 M(-9.9%) |
| June 2008 | - | $7.03 M(+124.8%) | $17.50 M(+29.3%) |
| Mar 2008 | - | $3.13 M(-5.0%) | $13.53 M(-18.8%) |
| Dec 2007 | $13.47 M(+2963.8%) | $3.29 M(-18.5%) | $16.66 M(+627.4%) |
| Sept 2007 | - | $4.04 M(+31.7%) | $2.29 M(+9.7%) |
| June 2007 | - | $3.07 M(-50.9%) | $2.09 M(-283.6%) |
| Mar 2007 | - | $6.26 M(-156.5%) | -$1.14 M(-77.5%) |
| Dec 2006 | $439.80 K(-109.2%) | -$11.08 M(-388.5%) | -$5.05 M(+85.6%) |
| Sept 2006 | - | $3.84 M(-2578.2%) | -$2.72 M(-39.1%) |
| June 2006 | - | -$154.90 K(-106.6%) | -$4.48 M(-26.2%) |
| Mar 2006 | - | $2.34 M(-126.7%) | -$6.07 M(-14.0%) |
| Dec 2005 | -$4.80 M(-2.9%) | -$8.75 M(-519.1%) | -$7.05 M(-608.0%) |
| Sept 2005 | - | $2.09 M(-219.6%) | $1.39 M(-160.6%) |
| June 2005 | - | -$1.74 M(-229.3%) | -$2.29 M(+10.6%) |
| Mar 2005 | - | $1.35 M(-545.8%) | -$2.07 M(-8.9%) |
| Dec 2004 | -$4.95 M(+834.5%) | -$302.70 K(-81.0%) | -$2.27 M(-63.8%) |
| Sept 2004 | - | -$1.59 M(+4.3%) | -$6.28 M(+56.5%) |
| June 2004 | - | -$1.53 M(-233.2%) | -$4.01 M(+61.3%) |
| Mar 2004 | - | $1.15 M(-126.6%) | -$2.49 M(-31.5%) |
| Dec 2003 | -$529.30 K(+276.5%) | -$4.31 M(-736.8%) | -$3.63 M(-636.8%) |
| Sept 2003 | - | $677.00 K | $677.00 K |
| Apr 2002 | -$140.60 K(-65.4%) | - | - |
| Apr 2001 | -$406.80 K(+14.4%) | - | - |
| Apr 2000 | -$355.70 K(+5372.3%) | - | - |
| Apr 1999 | -$6500.00 | - | - |
FAQ
- What is Sinovac Biotech annual operaing income?
- What is the all time high annual operating profit for Sinovac Biotech?
- What is the all time high quarterly operating profit for Sinovac Biotech?
- What is the all time high TTM operating profit for Sinovac Biotech?
What is Sinovac Biotech annual operaing income?
The current annual operating profit of SVA is -$524.30 M
What is the all time high annual operating profit for Sinovac Biotech?
Sinovac Biotech all-time high annual operaing income is $17.55 B
What is the all time high quarterly operating profit for Sinovac Biotech?
Sinovac Biotech all-time high quarterly operating income is $197.04 M
What is the all time high TTM operating profit for Sinovac Biotech?
Sinovac Biotech all-time high TTM operating income is $215.81 M